Hydroxyurea Use After Transitions of Care Among Young Adults With Sickle Cell Disease and Tennessee Medicaid Insurance.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 34643722.
- Also identified by DOI 10.1001/jamanetworkopen.2021.28971 and PMC identifier 8515209.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cohort study examines whether hydroxyurea use changes in young adults with sickle cell disease who are transitioning from pediatric to adult health care.
Medical subject headings
- Anemia, Sickle Cell
- Hydroxyurea
- Medicaid